Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.84%309.47M | 15.37%96.65M | 20.40%80.24M | 15.93%59.43M | 15.77%73.15M | 28.78%264.86M | 69.09%83.77M | 41.70%66.65M | 11.08%51.26M | 0.36%63.19M |
| Cost of revenue | 14.05%139.17M | 12.86%44.49M | 14.09%34.44M | 30.99%28.28M | 3.67%31.96M | 5.33%122.02M | 41.92%39.42M | -3.03%30.18M | -19.04%21.59M | 1.83%30.83M |
| Gross profit | 19.22%170.3M | 17.61%52.16M | 25.62%45.81M | 4.98%31.14M | 27.31%41.19M | 59.01%142.84M | 103.76%44.35M | 129.22%36.46M | 52.33%29.67M | -0.99%32.36M |
| Operating expense | 11.06%38.74M | 13.22%10.97M | 10.83%10.19M | 16.73%10.96M | -0.02%9.19M | -8.46%34.88M | 13.75%9.69M | -3.08%9.2M | -24.02%9.39M | 28.57%9.19M |
| Selling and administrative expenses | 10.28%41.31M | 13.22%10.97M | 10.83%10.19M | 16.73%10.96M | -0.02%9.19M | -0.12%37.46M | 13.75%9.69M | -3.08%9.2M | -24.02%9.39M | 28.57%9.19M |
| -Selling and marketing expense | 5.86%5.89M | 9.45%1.91M | 10.12%1.51M | -8.01%1.02M | 8.35%1.44M | 38.12%5.56M | 79.63%1.75M | 42.68%1.37M | 20.89%1.11M | 13.49%1.33M |
| -General and administrative expense | 11.05%35.43M | 14.05%9.06M | 10.96%8.68M | 20.05%9.94M | -1.44%7.75M | -4.72%31.9M | 5.26%7.94M | -8.25%7.82M | -27.63%8.28M | 31.52%7.87M |
| Other operating expenses | --134.15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other operating income | 4.98%2.71M | ---- | ---- | ---- | ---- | --2.58M | ---- | ---- | ---- | ---- |
| Operating profit | 21.86%131.56M | 18.83%41.19M | 30.61%35.62M | -0.46%20.19M | 38.15%32M | 108.71%107.96M | 161.61%34.66M | 324.68%27.27M | 184.77%20.28M | -9.27%23.16M |
| Net non-operating interest income (expenses) | 5.14%13.23M | -2.15%3.42M | 4.22%3.63M | 2.21%2.91M | 18.56%3.27M | 33.21%12.58M | 44.10%3.49M | 25.69%3.48M | 26.94%2.85M | 37.47%2.76M |
| Non-operating interest income | 6.29%14.2M | 3.67%3.82M | 3.84%3.82M | 1.94%3.1M | 17.10%3.46M | 34.46%13.36M | 40.82%3.68M | 23.81%3.68M | 29.96%3.05M | 47.18%2.95M |
| Non-operating interest expense | 25.03%964.87K | 109.95%401K | -3.13%186K | -2.06%190K | -3.59%188K | 58.87%771.69K | -0.52%191K | -2.54%192K | 100.00%194K | --195K |
| Net investment income | 172.19%5.67M | -54.64%2.21M | 949.12%2.39M | 892.00%1.24M | 6.79%566K | -83.78%2.08M | 45.84%4.88M | -88.45%228K | -38.42%125K | -37.05%530K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 52.19%329.1K | ||||||||
| Income from associates and other participating interests | 1,422.46%84.57M | 1,247.65%78.35M | 954.51%2.27M | -275.88%-1.2M | 36,678.57%5.15M | -6.09%-6.39M | -7.11%-6.83M | -129.56%-266K | 117.02%684K | -99.60%14K |
| Special income (charges) | 50.59%-355.43K | -3,772.77%-719.29K | ||||||||
| Less:Impairment of capital assets | -49.89%360.43K | ---- | ---- | ---- | ---- | 3,772.77%719.29K | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 36.18%2.21M | 207.93%3.12M | 162.03%343K | -94.06%159K | -92.14%71K | -11.07%1.62M | -141.82%-2.89M | -132.43%-553K | 1,742.33%2.68M | 264.48%903K |
| Income before tax | 101.67%236.88M | 285.06%128.28M | 46.72%44.25M | -12.48%23.3M | 50.02%41.06M | 67.80%117.46M | 70.43%33.32M | 119.01%30.16M | 393.84%26.62M | -12.54%27.37M |
| Income tax | 20.79%36.38M | 16.31%12.54M | 28.33%9.6M | -1.31%5.74M | 40.70%8.5M | 81.07%30.12M | 84.78%10.78M | 220.76%7.48M | 135.56%5.82M | 0.75%6.04M |
| Net income | 129.56%200.51M | 413.66%115.74M | 52.78%34.66M | -15.60%17.56M | 52.66%32.55M | 63.66%87.35M | 64.32%22.53M | 98.28%22.69M | 612.15%20.8M | -15.69%21.33M |
| Net income continuous operations | 129.56%200.51M | 413.66%115.74M | 52.78%34.66M | -15.60%17.56M | 52.66%32.55M | 63.66%87.35M | 64.32%22.53M | 98.28%22.69M | 612.15%20.8M | -15.69%21.33M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 129.56%200.51M | 413.66%115.74M | 52.78%34.66M | -15.60%17.56M | 52.66%32.55M | 63.66%87.35M | 64.32%22.53M | 98.28%22.69M | 612.15%20.8M | -15.69%21.33M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 129.56%200.51M | 413.66%115.74M | 52.78%34.66M | -15.60%17.56M | 52.66%32.55M | 63.66%87.35M | 64.32%22.53M | 98.28%22.69M | 612.15%20.8M | -15.69%21.33M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 129.56%2.1946 | 413.71%1.2668 | 52.80%0.3794 | -15.59%0.1922 | 52.66%0.3563 | 63.67%0.956 | 64.29%0.2466 | 98.32%0.2483 | 611.56%0.2277 | -15.71%0.2334 |
| Diluted earnings per share | 129.56%2.1946 | 413.71%1.2668 | 52.80%0.3794 | -15.59%0.1922 | 52.66%0.3563 | 63.67%0.956 | 64.29%0.2466 | 98.32%0.2483 | 611.56%0.2277 | -15.71%0.2334 |
| Dividend per share | 0.00%0.16 | 0.00%0.08 | 0 | 0.00%0.08 | 0 | 0.00%0.16 | 0.00%0.08 | 0 | 0.00%0.08 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.